BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22336008)

  • 21. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
    Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy and safety of subcutaneous immuno-therapy with dermatophagoides pteronyssinus for allergic rhinitis].
    Liu J; Wan J; Zhou Y; Liu Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 26(11):510-2. PubMed ID: 22934340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study on cluster and conventional immunotherapy in patients with allergic rhinitis].
    Luo Z; Li B; Wan L; Peng C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 50(2):105-9. PubMed ID: 25916529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of specific immunotherapy using a depigmented and polymerised extract of Dermatophagoides pteronyssinus in children under five years of age.
    Hernández N; Ibero M; Ridao M; Artigas R; Viñas M; Castillo MJ
    Allergol Immunopathol (Madr); 2011; 39(5):267-70. PubMed ID: 21334128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The results of specific immunotherapy for house dust mites in patients with allergic rhinitis].
    Sahin E; Taş E; Dağtekin Ergür EN; Cuhali BD; Gürsel AO
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(2):79-84. PubMed ID: 18628641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Efficacy Analysis of Cluster and Conventional Immunotherapy in Patients With Allergic Rhinitis.
    Yu J; Zhong N; Luo Q; Liu Y; Yi H; Ye J; Zhang J
    Ear Nose Throat J; 2021 Jun; 100(5):378-385. PubMed ID: 31547713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one.
    Mauro M; Russello M; Alesina R; Sillano V; Alessandrini A; Dama A; Passalacqua G; Senna G
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):31-4. PubMed ID: 16544586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study.
    Tabar AI; Fernández-Távora L; Alonso R; Castillo R; Cisteró-Bahima A; de la Torre-Morin F; Fernández J; García-Figueroa BE; Fernández S; García-González JJ; García-Robaina JC; Moreno F; Lobatón P; Sánchez-Machín I; de la Torre-Martínez F
    J Investig Allergol Clin Immunol; 2004; 14(3):193-7. PubMed ID: 15552712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety analysis with standardized mite allergen subcutaneous immunotherapy in 90 patients with allergic rhinitis].
    Li L; Guan GM; Zhu DD; Sha JC; Jin GH; Chen MX; Zhang H; Dong Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):445-8. PubMed ID: 22932133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.